• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD4 计数正常的 HIV 病毒血症控制者和非控制者的临床结局完全由抗原特异性 CD8 + T 细胞介导的 HIV 抑制作用决定。

Clinical outcome of HIV viraemic controllers and noncontrollers with normal CD4 counts is exclusively determined by antigen-specific CD8+ T-cell-mediated HIV suppression.

作者信息

Tansiri Yada, Rowland-Jones Sarah L, Ananworanich Jintanat, Hansasuta Pokrath

机构信息

Division of Virology, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Nuffield Department of Medicine, NDM Research Building, University of Oxford, Old Road Campus, Headington, OX3 7FZ, Oxford, United Kingdom.

出版信息

PLoS One. 2015 Mar 12;10(3):e0118871. doi: 10.1371/journal.pone.0118871. eCollection 2015.

DOI:10.1371/journal.pone.0118871
PMID:25764310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4357381/
Abstract

In this cross-sectional study we evaluated T-cell responses using several assays to determine immune correlates of HIV control that distinguish untreated viraemic controllers (VC) from noncontrollers (NC) with similar CD4 counts. Samples were taken from 65 ART-naïve chronically HIV-infected VC and NC from Thailand with matching CD4 counts in the normal range (>450 cells/μl). We determined HIVp24-specific T-cell responses using standard Interferon-gamma (IFNγ) ELISpot assays, and compared the functional quality of HIVp24-specific CD8+ T-cell responses using polychromatic flow cytometry. Finally, in vitro HIV suppression assays were performed to evaluate directly the activity of CD8+ T cells in HIV control. Autologous CD4+ T cells were infected with primary patient-derived HIV isolates and the HIV suppressive activity of CD8+ T cells was determined after co-culture, measuring production of HIVp24 Ag by ELISA. The HIVp24-specific T-cell responses of VC and NC could not completely be differentiated through measurement of IFNγ-producing cells using ELISpot assays, nor by the absolute cell numbers of polyfunctional HIVp24-specific CD8+ T cells. However, in vitro HIV suppression assays showed clear differences between VC and NC. HIV suppressive activity, mediated by either ex vivo unstimulated CD8+ T cells or HIVp24-specific T-cell lines, was significantly greater using cells from VC than NC cells. Additionally, we were able to demonstrate a significant correlation between the level of HIV suppressive activity mediated by ex vivo unstimulated CD8+ T cells and plasma viral load (pVL) (Spearman r = -0.7345, p = 0.0003). This study provides evidence that in vitro HIV suppression assays are the most informative in the functional evaluation of CD8+ T-cell responses and can distinguish between VC and NC.

摘要

在这项横断面研究中,我们使用多种检测方法评估T细胞反应,以确定区分未经治疗的病毒血症控制者(VC)和具有相似CD4计数的非控制者(NC)的HIV控制免疫相关因素。样本取自65名来自泰国的初治慢性HIV感染者,这些VC和NC的CD4计数在正常范围内(>450个细胞/μl)。我们使用标准的干扰素-γ(IFNγ)酶联免疫斑点分析(ELISpot)来确定HIV p24特异性T细胞反应,并使用多色流式细胞术比较HIV p24特异性CD8+ T细胞反应的功能质量。最后,进行体外HIV抑制试验以直接评估CD8+ T细胞在HIV控制中的活性。用原发性患者来源的HIV分离株感染自体CD4+ T细胞,并在共培养后通过ELISA测量HIV p24抗原的产生来确定CD8+ T细胞的HIV抑制活性。通过ELISpot分析测量产生IFNγ的细胞,或通过多功能HIV p24特异性CD8+ T细胞的绝对细胞数,无法完全区分VC和NC的HIV p24特异性T细胞反应。然而,体外HIV抑制试验显示VC和NC之间存在明显差异。使用来自VC的细胞比NC细胞,由体外未刺激的CD8+ T细胞或HIV p24特异性T细胞系介导的HIV抑制活性显著更高。此外,我们能够证明体外未刺激的CD8+ T细胞介导的HIV抑制活性水平与血浆病毒载量(pVL)之间存在显著相关性(Spearman相关系数r = -0.7345,p = 0.0003)。这项研究提供了证据,表明体外HIV抑制试验在CD8+ T细胞反应的功能评估中最具信息价值,并且可以区分VC和NC。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8305/4357381/e77968f1aad0/pone.0118871.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8305/4357381/d433218827c2/pone.0118871.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8305/4357381/255230c65e80/pone.0118871.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8305/4357381/7a5c74f04d02/pone.0118871.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8305/4357381/ff55820d4660/pone.0118871.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8305/4357381/e77968f1aad0/pone.0118871.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8305/4357381/d433218827c2/pone.0118871.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8305/4357381/255230c65e80/pone.0118871.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8305/4357381/7a5c74f04d02/pone.0118871.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8305/4357381/ff55820d4660/pone.0118871.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8305/4357381/e77968f1aad0/pone.0118871.g005.jpg

相似文献

1
Clinical outcome of HIV viraemic controllers and noncontrollers with normal CD4 counts is exclusively determined by antigen-specific CD8+ T-cell-mediated HIV suppression.CD4 计数正常的 HIV 病毒血症控制者和非控制者的临床结局完全由抗原特异性 CD8 + T 细胞介导的 HIV 抑制作用决定。
PLoS One. 2015 Mar 12;10(3):e0118871. doi: 10.1371/journal.pone.0118871. eCollection 2015.
2
Poor HIV control in HLA-B*27 and B*57/58 noncontrollers is associated with limited number of polyfunctional Gag p24-specific CD8+ T cells.HLA-B*27 和 B*57/58 非控制者中 HIV 控制不佳与 Gag p24 特异性 CD8+ T 细胞的多功能性数量有限有关。
AIDS. 2013 Jan 2;27(1):17-27. doi: 10.1097/QAD.0b013e32835ac0e1.
3
Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.HIV 病毒控制者和非控制者脑脊液中的免疫激活与 HIV 特异性 CD8(+) T 细胞
AIDS Res Hum Retroviruses. 2016 Aug;32(8):791-800. doi: 10.1089/AID.2015.0313. Epub 2016 May 2.
4
Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or function.抗逆转录病毒治疗期间对HIV p24的增殖反应并不能反映免疫表型或功能的改善。
AIDS. 2004 Mar 5;18(4):605-13. doi: 10.1097/00002030-200403050-00004.
5
HIV-specific IL-2(+) and/or IFN-γ(+) CD8(+) T cell responses during chronic HIV-1 infection in former blood donors.慢性 HIV-1 感染的前献血者中 HIV 特异性 IL-2(+)和/或 IFN-γ(+)CD8(+)T 细胞应答。
Biomed Environ Sci. 2010 Oct;23(5):391-401. doi: 10.1016/S0895-3988(10)60081-5.
6
HIV-1-specific CD4+ T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia.在持续性血浆病毒血症患者中,HIV-1特异性CD4+ T细胞反应与显著的病毒表位变异无关。
J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):140-8. doi: 10.1097/01.qai.0000195608.32885.38.
7
HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children.HIV复制导致受感染儿童CD8阳性T细胞反应的成熟出现偏差。
New Microbiol. 2010 Oct;33(4):303-9.
8
HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.接受高效抗逆转录病毒治疗的HIV-1感染儿童:三种不同病毒抑制水平的免疫学特征。
Cytometry B Clin Cytom. 2007 Jan 15;72(1):14-21. doi: 10.1002/cyto.b.20152.
9
Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression.一名CD4+细胞计数较高的HIV感染者中病毒特异性CD8+细胞毒性T淋巴细胞活性延迟:与疾病进展的各种参数的相关性
AIDS Res Hum Retroviruses. 1996 Apr 10;12(6):497-506. doi: 10.1089/aid.1996.12.497.
10
Potent immune responses of Ag-specific Vgamma2Vdelta2+ T cells and CD8+ T cells associated with latent stage of Mycobacterium tuberculosis coinfection in HIV-1-infected humans.在HIV-1感染的人类中,与结核分枝杆菌合并感染潜伏期相关的抗原特异性Vγ2Vδ2 + T细胞和CD8 + T细胞的强效免疫反应。
AIDS. 2008 Nov 12;22(17):2241-50. doi: 10.1097/QAD.0b013e3283117f18.

引用本文的文献

1
Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo data.早期 CD8 T 细胞反应的抗病毒能力可预测 SIV 感染的自然控制:使用体外数据了解体内动力学。
PLoS Comput Biol. 2024 Sep 10;20(9):e1012434. doi: 10.1371/journal.pcbi.1012434. eCollection 2024 Sep.
2
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8 T-cells.早期抗逆转录病毒治疗有利于治疗后 SIV 控制,与增强的记忆性 CD8 T 细胞的扩增相关。
Nat Commun. 2024 Jan 11;15(1):178. doi: 10.1038/s41467-023-44389-3.
3

本文引用的文献

1
CD8 T-cells from most HIV-infected patients lack ex vivo HIV-suppressive capacity during acute and early infection.在急性和早期感染期间,大多数 HIV 感染患者的 CD8 T 细胞缺乏体外 HIV 抑制能力。
PLoS One. 2013;8(3):e59767. doi: 10.1371/journal.pone.0059767. Epub 2013 Mar 29.
2
Poor HIV control in HLA-B*27 and B*57/58 noncontrollers is associated with limited number of polyfunctional Gag p24-specific CD8+ T cells.HLA-B*27 和 B*57/58 非控制者中 HIV 控制不佳与 Gag p24 特异性 CD8+ T 细胞的多功能性数量有限有关。
AIDS. 2013 Jan 2;27(1):17-27. doi: 10.1097/QAD.0b013e32835ac0e1.
3
Antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ T-cell decline in HIV-1 infection.
Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles.
在具有和不具有保护性 HLA 等位基因的抗逆转录病毒初治 HIV-1 病毒血症控制者中,自然杀伤细胞、T 细胞和抗体的特征存在差异。
PLoS One. 2023 Jun 2;18(6):e0286507. doi: 10.1371/journal.pone.0286507. eCollection 2023.
4
CCR5∆32 and SDF1 3'A: Gene Variants, Expression and Influence on Biological Markers for the Clinical Progression to AIDS among HIV-1 Virus Controllers in a Mixed Population of the Amazon Region of Brazil.CCR5∆32 和 SDF1 3'A:基因变异、表达及其对巴西亚马逊地区混合人群中 HIV-1 病毒控制者向艾滋病临床进展的生物学标志物的影响。
Int J Mol Sci. 2023 Mar 4;24(5):4958. doi: 10.3390/ijms24054958.
5
Mechanism of Viral Suppression among HIV Elite Controllers and Long-Term Nonprogressors in Nigeria and South Africa.尼日利亚和南非的 HIV 精英控制者和长期非进展者中病毒抑制的机制。
Viruses. 2022 Jun 10;14(6):1270. doi: 10.3390/v14061270.
6
Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil.巴西北部地区HIV-1病毒血症控制者的免疫学和病毒学特征
BMC Infect Dis. 2017 Jun 1;17(1):381. doi: 10.1186/s12879-017-2491-9.
7
Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8 T Cells.初免-加强免疫通过产生高亲和力效应性CD8 T细胞消除转移性结直肠癌。
J Immunol. 2017 May 1;198(9):3507-3514. doi: 10.4049/jimmunol.1502672. Epub 2017 Mar 24.
CD8+ T细胞的抗病毒抑制能力可预测HIV-1感染中CD4+ T细胞的下降速率。
J Infect Dis. 2012 Aug 15;206(4):552-61. doi: 10.1093/infdis/jis379. Epub 2012 Jun 18.
4
TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection.T 细胞受体克隆型调节人类免疫缺陷病毒 1 感染中 HLA Ⅰ类分子的保护作用。
Nat Immunol. 2012 Jun 10;13(7):691-700. doi: 10.1038/ni.2342.
5
High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.高功能性、高亲和力细胞毒性 T 淋巴细胞对与相对 HIV 控制相关的 HLA-B 限制性 Gag 衍生表位的反应。
J Virol. 2011 Sep;85(18):9334-45. doi: 10.1128/JVI.00460-11. Epub 2011 Jul 13.
6
Multilayered defense in HLA-B51-associated HIV viral control.多层防御在 HLA-B51 相关的 HIV 病毒控制中。
J Immunol. 2011 Jul 15;187(2):684-91. doi: 10.4049/jimmunol.1100316. Epub 2011 Jun 13.
7
Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression.人类免疫缺陷病毒 1 型长期非进展者:疾病不进展的病毒、遗传和免疫学基础。
J Gen Virol. 2011 Feb;92(Pt 2):247-68. doi: 10.1099/vir.0.027102-0. Epub 2010 Nov 24.
8
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.HIV-1 控制的主要遗传决定因素影响 HLA Ⅰ类肽的呈递。
Science. 2010 Dec 10;330(6010):1551-7. doi: 10.1126/science.1195271. Epub 2010 Nov 4.
9
Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses.基于体外 T 细胞的 HIV 抑制测定法,用于评估 HIV 特异性 CD8+ T 细胞应答。
Nat Protoc. 2010 Jun;5(6):1033-41. doi: 10.1038/nprot.2010.73. Epub 2010 May 13.
10
Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.HIV 特异性 CD8 T 细胞的体外穿孔素表达是 HIV 精英控制的相关因素。
PLoS Pathog. 2010 May 27;6(5):e1000917. doi: 10.1371/journal.ppat.1000917.